Record-Breaking Sales for the Week Ending on August 31, 2024
Strong Demand throughout July and August Drives Revenue; Anticipation to Exceed the High End of the Previously Announced Revenue Guidance of $39 million to $41 million
VANCOUVER, BC, Sept. 4, 2024 /CNW/ - Kits Eyecare Ltd. (TSX:KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, announces an upward revision to the Company's Q3 2024 revenue guidance.
The Company expects Q3 revenue to exceed the previously guided range of $39 million to $41 million. The revised revenue outlook will exceed 32% growth rate year-over-year.
This revision follows a record-breaking week of ordered sales of approximately $3.5 million for the week ending August 31, 2024. This performance, including records in sales Canada, has contributed significantly to the increased confidence in the Company's Q3 guidance.
In the Q2 2024 earnings release, KITS provided a revenue guidance range of $39 million to $41 million for ...
